Abstract
In this issue of Cancer Cell, Nickeleit et al. (2008) identify a new proteasome inhibitor, argyrin A, and show that it induces apoptosis and inhibits angiogenesis via p27-dependent mechanisms. Their observations challenge current thinking about how this class of promising cancer therapies works and why they selectively kill cancer cells.
Original language | English (US) |
---|---|
Pages (from-to) | 1-2 |
Number of pages | 2 |
Journal | Cancer cell |
Volume | 14 |
Issue number | 1 |
DOIs | |
State | Published - Jul 8 2008 |
Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Cell Biology
- Cancer Research